| TMS-EEG signatures of GABAergic neurotransmission in the human cortex I Premoli, N Castellanos, D Rivolta, P Belardinelli, R Bajo, C Zipser, ... Journal of Neuroscience 34 (16), 5603-5612, 2014 | 354 | 2014 |
| Cell-based and stem-cell-based treatments for spinal cord injury: evidence from clinical trials CM Zipser, JJ Cragg, JD Guest, MG Fehlings, CR Jutzeler, AJ Anderson, ... The Lancet Neurology 21 (7), 659-670, 2022 | 112 | 2022 |
| Effects of the selective α5-GABAAR antagonist S44819 on excitability in the human brain: a TMS–EMG and TMS–EEG phase I study G Darmani, CM Zipser, GM Böhmer, K Deschet, F Müller-Dahlhaus, ... Journal of Neuroscience 36 (49), 12312-12320, 2016 | 108 | 2016 |
| Effects of antiepileptic drugs on cortical excitability in humans: A TMS‐EMG and TMS‐EEG study G Darmani, TO Bergmann, C Zipser, D Baur, F Müller‐Dahlhaus, ... Human brain mapping 40 (4), 1276-1289, 2019 | 73 | 2019 |
| TMS-EEG signatures of glutamatergic neurotransmission in human cortex P Belardinelli, F König, C Liang, I Premoli, D Desideri, F Müller-Dahlhaus, ... Scientific reports 11 (1), 8159, 2021 | 71 | 2021 |
| Short-interval and long-interval intracortical inhibition of TMS-evoked EEG potentials I Premoli, J Király, F Müller-Dahlhaus, CM Zipser, P Rossini, C Zrenner, ... Brain stimulation 11 (4), 818-827, 2018 | 70 | 2018 |
| The effects of NMDA receptor blockade on TMS-evoked EEG potentials from prefrontal and parietal cortex NC Rogasch, C Zipser, G Darmani, TP Mutanen, M Biabani, C Zrenner, ... Scientific reports 10 (1), 3168, 2020 | 57 | 2020 |
| Cerebrospinal fluid biogenic amines depletion and brain atrophy in adult patients with phenylketonuria A Pilotto, N Blau, E Leks, C Schulte, C Deuschl, C Zipser, D Piel, ... Journal of inherited metabolic disease 42 (3), 398-406, 2019 | 45 | 2019 |
| Cortical excitability and interhemispheric connectivity in early relapsing–remitting multiple sclerosis studied with TMS-EEG CM Zipser, I Premoli, P Belardinelli, N Castellanos, D Rivolta, ... Frontiers in neuroscience 12, 358449, 2018 | 39 | 2018 |
| A new framework for investigating the biological basis of degenerative cervical myelopathy [AO Spine RECODE-DCM Research Priority Number 5]: mechanical stress, vulnerability … BM Davies, O Mowforth, AA Gharooni, L Tetreault, A Nouri, RS Dhillon, ... Global spine journal 12 (1_suppl), 78S-96S, 2022 | 36 | 2022 |
| We choose to call it ‘degenerative cervical myelopathy’: findings of AO spine recode-dcm, an international and multi-stakeholder partnership to agree a standard unifying term … BM Davies, DZ Khan, K Barzangi, A Ali, OD Mowforth, A Nouri, JS Harrop, ... Global spine journal 14 (2), 503-512, 2024 | 32 | 2024 |
| Phenylalanine effects on brain function in adult phenylketonuria A Pilotto, CM Zipser, E Leks, D Haas, G Gramer, P Freisinger, E Schaeffer, ... Neurology 96 (3), e399-e411, 2021 | 32 | 2021 |
| The predisposing and precipitating risk factors for delirium in neurosurgery: a prospective cohort study of 949 patients CM Zipser, J Deuel, J Ernst, M Schubert, R von Känel, S Böttger Acta neurochirurgica 161, 1307-1315, 2019 | 30 | 2019 |
| Improving awareness could transform outcomes in degenerative cervical myelopathy [AO Spine RECODE-DCM Research Priority Number 1] BM Davies, O Mowforth, H Wood, Z Karimi, I Sadler, L Tetreault, J Milligan, ... Global spine journal 12 (1_suppl), 28S-38S, 2022 | 28 | 2022 |
| Predisposing and precipitating factors for delirium in neurology: a prospective cohort study of 1487 patients CM Zipser, J Deuel, J Ernst, M Schubert, M Weller, R von Känel, ... Journal of neurology 266, 3065-3075, 2019 | 27 | 2019 |
| The prevalence rates and adversities of delirium: Too common and disadvantageous S Boettger, CM Zipser, L Bode, T Spiller, J Deuel, G Osterhoff, J Ernst, ... Palliative & supportive care 19 (2), 161-169, 2021 | 24 | 2021 |
| The restless spinal cord in degenerative cervical myelopathy M Hupp, N Pfender, K Vallotton, J Rosner, S Friedl, CM Zipser, R Sutter, ... American Journal of Neuroradiology 42 (3), 597-609, 2021 | 21 | 2021 |
| Establishing diagnostic criteria for degenerative cervical myelopathy [AO Spine RECODE-DCM Research Priority Number 3] B Hilton, EL Gardner, Z Jiang, L Tetreault, JRF Wilson, CM Zipser, ... Global spine journal 12 (1_suppl), 55S-63S, 2022 | 20 | 2022 |
| Clinical outcome measures and their evidence base in degenerative cervical myelopathy: a systematic review to inform a core measurement set (AO Spine RECODE-DCM) AY Touzet, A Bhatti, E Dohle, F Bhatti, KS Lee, JC Furlan, MG Fehlings, ... BMJ open 12 (1), e057650, 2022 | 20 | 2022 |
| Increasing awareness of degenerative cervical myelopathy: a preventative cause of non-traumatic spinal cord injury CM Zipser, K Margetis, KM Pedro, A Curt, M Fehlings, I Sadler, L Tetreault, ... Spinal Cord 59 (11), 1216-1218, 2021 | 15 | 2021 |
